BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Staging
67 results:

  • 1. Key learnings from concordant systematic biopsies in prostate-specific membrane antigen positron emission tomography/computed tomography-guided prostate biopsies: Enhancing targeting accuracy.
    Büttner T; Gärtner F; Essler M; Weiten R; Kristiansen G; Ellinger J; Ritter M; Krausewitz P
    Prostate; 2024 Jun; 84(8):772-779. PubMed ID: 38504659
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Combination of [
    Kim J; Lee S; Kim D; Kim HJ; Oh KT; Kim SJ; Choi YD; Giesel FL; Kopka K; Hoepping A; Lee M; Yun M
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1763-1772. PubMed ID: 38200396
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Intense 18 F-PSMA-1007 Uptake of Splenic Hemangioma.
    Jia G; Dong A; Cheng C; Zuo C
    Clin Nucl Med; 2024 Feb; 49(2):e90-e92. PubMed ID: 38048527
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Intra-individual comparison of prostate-specific membrane antigen positron emission tomography/computed tomography versus bone scan in detecting skeletal metastasis at prostate cancer diagnosis.
    Shanmugasundaram R; Saad J; Heyworth A; Wong V; Pelecanos A; Arianayagam M; Canagasingham B; Ferguson R; Goolam AS; Khadra M; Kam J; Ko R; McCombie S; Varol C; Winter M; Mansberg R; Nguyen D; Bui C; Loh H; Le K; Roberts MJ
    BJU Int; 2024 Feb; 133 Suppl 3():25-32. PubMed ID: 37943964
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Impact of uptake time on image quality of [
    van der Sar ECA; Viol SLM; Braat AJAT; van Rooij R; Lam MGEH; de Jong HWAM; de Keizer B
    Med Phys; 2023 Dec; 50(12):7619-7628. PubMed ID: 37093883
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The roles of 68 Ga-PSMA PET/CT and 18 F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings.
    Arslan E; Ergül N; Beyhan E; Erol Fenercioglu Ö; Sahin R; Cin M; Battal Havare S; Can Trabulus FD; Mermut Ö; Akbas S; Fikret Çermik T
    Nucl Med Commun; 2023 Apr; 44(4):284-290. PubMed ID: 36756767
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Head-to-Head Comparison of 68 Ga-P16-093 and 68 Ga-PSMA-617 PET/CT in Patients With Primary prostate cancer : A Pilot Study.
    Wang G; Li L; Zang J; Hong H; Zhu L; Kung HF; Zhu Z
    Clin Nucl Med; 2023 Apr; 48(4):289-295. PubMed ID: 36727866
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [The intensity of PSMA intraprostatic uptake as a predictor of clinically significant prostate cancer].
    Bergero MA; Costa L; Modina P; Carlos D; Arceluz MJ; Faccio FF
    Medicina (B Aires); 2022; 82(6):845-850. PubMed ID: 36571522
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comparison of 18 F-PSMA-1007 PET/CT With 68 Ga-PSMA-11 PET/CT for Initial staging in Intermediate- and High-Risk prostate cancer.
    Chandekar KR; Singh H; Kumar R; Kumar S; Kakkar N; Mittal BR; Singh SK
    Clin Nucl Med; 2023 Jan; 48(1):e1-e8. PubMed ID: 36240786
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Comparison of
    Schollhammer R; Robert G; Asselineau J; Yacoub M; Vimont D; Balamoutoff N; Bladou F; Bénard A; Hindié E; Gallerande HC; Morgat C
    J Nucl Med; 2023 Mar; 64(3):379-385. PubMed ID: 36215569
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Special issue "The advance of solid tumor research in China": 68Ga-PSMA-11 PET/CT for evaluating primary and metastatic lesions in different histological subtypes of renal cell carcinoma.
    Li Y; Zheng R; Zhang Y; Huang C; Tian L; Liu R; Liu Y; Zhang Z; Han H; Zhou F; He L; Dong P
    Int J Cancer; 2023 Jan; 152(1):42-50. PubMed ID: 35751420
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Optimization of ODAP-Urea-based dual-modality PSMA targeting probes for sequential PET-CT and optical imaging.
    Li Y; Duan X; Xu H; Zhang J; Zhou H; Zhang X; Zhang J; Yang Z; Hu Z; Zhang N; Tian J; Yang X
    Bioorg Med Chem; 2022 Jul; 66():116810. PubMed ID: 35580538
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Bone Uptake in prostate cancer Patients: Diagnostic Performances of PSMA-RADS v1.0, Clinical, Biological, and 68 Ga-PSMA-11 PET Features to Predict Metastasis After Biochemical Recurrence.
    Letang A; Crombé A; Rousseau C; Sargos P; Merlin C; Cantarel C; Cazeau AL
    Clin Nucl Med; 2022 Aug; 47(8):e529-e539. PubMed ID: 35543633
    [TBL] [Abstract] [Full Text] [Related]  

  • 14.
    Moradi F; Duan H; Song H; Davidzon GA; Chung BI; Thong AEC; Loening AM; Ghanouni P; Sonn G; Iagaru A
    J Nucl Med; 2022 Dec; 63(12):1822-1828. PubMed ID: 35512996
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Infiltrative growth pattern of prostate cancer is associated with lower uptake on PSMA PET and reduced diffusion restriction on mpMRI.
    Laudicella R; Rüschoff JH; Ferraro DA; Brada MD; Hausmann D; Mebert I; Maurer A; Hermanns T; Eberli D; Rupp NJ; Burger IA
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3917-3928. PubMed ID: 35435496
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Hot needles can confirm accurate lesion sampling intraoperatively using [
    Ferraro DA; Laudicella R; Zeimpekis K; Mebert I; Müller J; Maurer A; Grünig H; Donati O; Sapienza MT; Rueschoff JH; Rupp N; Eberli D; Burger IA
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1721-1730. PubMed ID: 34725726
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Artificial intelligence-based measurements of PET/CT imaging biomarkers are associated with disease-specific survival of high-risk prostate cancer patients.
    Polymeri E; Kjölhede H; Enqvist O; Ulén J; Poulsen MH; Simonsen JA; Borrelli P; Trägårdh E; Johnsson ÅA; Høilund-Carlsen PF; Edenbrandt L
    Scand J Urol; 2021 Dec; 55(6):427-433. PubMed ID: 34565290
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Detection of Additional Primary Neoplasms on
    Parihar AS; Schmidt LR; Dehdashti F; Wahl RL
    J Nucl Med; 2022 May; 63(5):713-719. PubMed ID: 34413144
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. What's behind
    Rüschoff JH; Ferraro DA; Muehlematter UJ; Laudicella R; Hermanns T; Rodewald AK; Moch H; Eberli D; Burger IA; Rupp NJ
    Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):4042-4053. PubMed ID: 34386839
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Focal unspecific bone uptake on [
    Grünig H; Maurer A; Thali Y; Kovacs Z; Strobel K; Burger IA; Müller J
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4483-4494. PubMed ID: 34120201
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.